不同剂量康复新液对Ⅱ期压疮患者临床疗效的研究

2020-09-02 MedSci原创 MedSci原创

研究结果证实,Ⅱ期压疮患者采用8层浸湿康复新液的无菌纱布覆盖创面、每天换药 2 次,可显著降低 PUSH 评分,缩短创面愈合时间,提高临床疗效。康复新液治疗压疮疗效确切且价格低廉,值得在临床进一步推广

      压疮是全球关注的重要患者安全问题之一。压疮又称压力性溃疡、褥疮,是由于局部组织长期受压,发生持续缺血、缺氧、营养不良而致组织溃烂坏死。皮肤压疮在康复治疗、护理中是一个常见的问题。据有关文献报道,每年约有6万人死于压疮并发症。

      压疮的发生给患者身心带来的痛苦,严重降低其生活质量,延长住院时间,影响疾病治疗和康复,增加医疗护理负担。研究者们在前期动物实验研究证实,较高剂量的康复新液可通过促进皮肤碱性成纤维细胞生长因子、转化生长因子、表皮生长因子的表达,从而修复早期压疮创面,促进压疮愈合。但目前临床研究尚未界定康复新液治疗压疮的剂量和换药频率。故本研究通过对Ⅱ期压疮患者采用康复新液不同剂量、不同换药频率治疗,探讨康复新液用于压疮换药的较好使用剂量和换药次数,以期为压疮的临床护理提供循证证据

        康复新液不同剂量不同换药频率治疗Ⅱ期压疮患者疗效

        一、对象

       选取2016年6月~2018年4月在某三甲医院住院的Ⅱ期压疮患者120例。纳入标准:符合 2009 年美国国家压疮咨询委员会( National Pressure Ulcer Advisory Panel, NPUAP)压疮分期法确诊为Ⅱ期压疮的住院患者。

        二、方法

       120例患者随机分为A、B、C、D四组,各30例,在常规护理和清创的基础上,四组患者均给予康复新液均匀喷洒创面,常规护理:积极治疗原发疾病,所有患者均给予常规护理。具体如下: 给予医用气垫床; 建立翻身记录卡,每1~2小时翻身一次,检查受压皮肤状况并做好记录,翻身时忌脱、拉、拽、推等易损伤皮肤的动作; 保持皮肤和床单位的清洁干燥,促进患者舒适;鼓励患者每天行2~3次主动或被动肢体运动;病情允许的情况下给予高蛋白、高热量、高维生素饮食,适当补充矿物质,尤其是维生素 C 和锌的摄入。

       常规护理:积极治疗原发疾病,所有患者均给予常规护理。具体如下: 给予医用气垫床; 建立翻身记录卡,每1~2小时翻身一次,检查受压皮肤状况并做好记录,翻身时忌脱、拉、拽、推等易损伤皮肤的动作; 保持皮肤和床单位的清洁干燥,促进患者舒适;鼓励患者每天行2~3次主动或被动肢体运动;病情允许的情况下给予高蛋白、高热量、高维生素饮食,适当补充矿物质,尤其是维生素 C 和锌的摄入。

       分组治疗:在常规护理的基础上,四组患者均给予康复新液治疗。具体如下: ①协助患者充分暴露创面,使用无菌生理盐水冲洗创面及创周皮肤,在无菌操作下剪去翘起的坏死组织或易脱落的痂壳,创周皮肤用碘伏消毒; ②将康复新液(四川好医生攀西药业有限责任公司,国药准字 Z51021834均匀喷洒于创面; ③分组治疗: A 组采用 4 层浸湿康复新液的无菌纱布(浸有药液的纱布潮湿但不滴药即可)覆盖创面,其外用无菌敷料及医用胶带遮盖固定妥当,每天定时换药 1 次; B 组的治疗方法同 A 组,每天定时换药 2 次; C 组采用 8 层浸湿康复新液的无菌纱布覆盖创面,其外用无菌敷料及医用胶带遮盖固定妥当,每天定时换药1次; D 组治疗方法同 C 组,每天定时换药2次。

       共干预21d。在干预前、干预后7d、14d、21d比较四组患者压疮愈合评分表( PUSH) ; 干预后21d,比较四组患者创面愈合时间及临床疗效。

        三、结果

       治疗后7d、14d、21d 四组患PUSH得分均较治疗前降低,差异有统计学意义( P<0. 05) 。治疗后14d,B组和D组PUSH得分低于A组和C组,差异有统计学意义( P<0. 05) ;治疗后21 d,D组PUSH得分<B 组<C 组<A 组,差异均有统计学意义( P<0. 05)。创面愈合时间,D组<B 组<C 组<A 组,差异均有统计学意义( P<0. 05)。临床疗效方面,D组总有效率优于B组,B 组优于C组,C组优于A组,差异有统计学意义( F=4. 491,P<0. 05)。

 

修复前

        四、结论

        Ⅱ期压疮患者采用8层浸湿康复新液的无菌纱布覆盖创面、每天换药2次,可显著降低PUSH评分,缩短创面愈合时间,提高临床疗效。

 

修复后

 

      五、讨论

      压疮是由于局部组织长期受压,导致血液循环障碍,局部持续缺血、缺氧、营养不良而致的软组织溃烂、坏死。湿性愈合理论认为应用敷料使创面维持湿润环境,不仅能保护创面免受污染和损伤,吸收伤口渗出液、减轻水肿,同时能帮助溶解创面坏死组织,有利于细胞增殖分化和移行,降低感染几率,促进创面愈合。

      目前治疗压疮的敷料类型较多,但普遍价格较高。康复新液是从美洲大蠊药材提取中分离、精制而成的生物制剂,美洲大蠊始载于《神农本草经》,其性寒味,咸,能理气散结、益气养阴、解毒生肌。现代药理学研究发现,康复新液含有的多元醇类、肽类物质及黏糖氨酸能改善伤口局部微循环,加速修复机体的病损组织,可有效促进伤口的愈合,疗效确切且价格低廉。本研究结果发现,在PUSH得分、创面愈合时间、临床疗效方面,D 组优于B组,B 组优于C组,C组优于A 组,差异均有统计学意义( P<0. 05) 。即采用8层浸湿康复新液的无菌纱布覆盖创面,每天换药2次的疗效最优;采用4层浸湿康复新液的无菌纱布覆盖创面,每天换药2次的疗效次之。说明高剂量的康复新液较之低剂量的康复新液更能促进压疮创面愈合,这与动物实验结果一致。

       动物实验证实低剂量的康复新液仅可以促进皮肤碱性成纤维细胞生长因子的表达,从而刺激生长因子的分泌和合成,加速早期压疮创面的修复; 而较高剂量的康复新液不仅可以促进皮肤碱性成纤维细胞生长因子的表达,还可以促进转化生长因子和表皮生长因子的表达,后两者对早期创面的加速修复具有辅助作用。相关研究表明,对于压疮患者,每天换药2次,能维持创面局部湿润环境,保证药液浓度,为患者创面肉芽组织生长提供了有利环境,同时避免过度频繁换药对患者新生血管和肉芽组织的损伤。

       研究结果证实,Ⅱ期压疮患者采用8层浸湿康复新液的无菌纱布覆盖创面、每天换药 2 次,可显著降低 PUSH 评分,缩短创面愈合时间,提高临床疗效。康复新液治疗压疮疗效确切且价格低廉,值得在临床进一步推广使用。

 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032020, encodeId=3305203202015, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Mar 05 09:48:17 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907203, encodeId=d888190e20356, content=<a href='/topic/show?id=acc02289e40' target=_blank style='color:#2F92EE;'>#临床疗效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22897, encryptionId=acc02289e40, topicName=临床疗效)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 23 23:48:17 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882436, encodeId=8dbd8824365f, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa05412020, createdName=韩杰, createdTime=Thu Sep 03 12:13:05 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882380, encodeId=f4ca8823805f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:27:32 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032634, encodeId=970c10326346d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Sep 02 20:48:17 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2021-03-05 clmlylxy
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032020, encodeId=3305203202015, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Mar 05 09:48:17 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907203, encodeId=d888190e20356, content=<a href='/topic/show?id=acc02289e40' target=_blank style='color:#2F92EE;'>#临床疗效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22897, encryptionId=acc02289e40, topicName=临床疗效)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 23 23:48:17 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882436, encodeId=8dbd8824365f, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa05412020, createdName=韩杰, createdTime=Thu Sep 03 12:13:05 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882380, encodeId=f4ca8823805f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:27:32 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032634, encodeId=970c10326346d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Sep 02 20:48:17 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032020, encodeId=3305203202015, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Mar 05 09:48:17 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907203, encodeId=d888190e20356, content=<a href='/topic/show?id=acc02289e40' target=_blank style='color:#2F92EE;'>#临床疗效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22897, encryptionId=acc02289e40, topicName=临床疗效)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 23 23:48:17 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882436, encodeId=8dbd8824365f, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa05412020, createdName=韩杰, createdTime=Thu Sep 03 12:13:05 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882380, encodeId=f4ca8823805f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:27:32 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032634, encodeId=970c10326346d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Sep 02 20:48:17 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-03 韩杰

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2032020, encodeId=3305203202015, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Mar 05 09:48:17 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907203, encodeId=d888190e20356, content=<a href='/topic/show?id=acc02289e40' target=_blank style='color:#2F92EE;'>#临床疗效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22897, encryptionId=acc02289e40, topicName=临床疗效)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 23 23:48:17 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882436, encodeId=8dbd8824365f, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa05412020, createdName=韩杰, createdTime=Thu Sep 03 12:13:05 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882380, encodeId=f4ca8823805f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:27:32 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032634, encodeId=970c10326346d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Sep 02 20:48:17 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-03 14818eb4m67暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2032020, encodeId=3305203202015, content=<a href='/topic/show?id=de0e4943257' target=_blank style='color:#2F92EE;'>#康复新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49432, encryptionId=de0e4943257, topicName=康复新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Mar 05 09:48:17 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1907203, encodeId=d888190e20356, content=<a href='/topic/show?id=acc02289e40' target=_blank style='color:#2F92EE;'>#临床疗效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22897, encryptionId=acc02289e40, topicName=临床疗效)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 23 23:48:17 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882436, encodeId=8dbd8824365f, content=实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5aa05412020, createdName=韩杰, createdTime=Thu Sep 03 12:13:05 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882380, encodeId=f4ca8823805f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Sep 03 08:27:32 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032634, encodeId=970c10326346d, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Wed Sep 02 20:48:17 CST 2020, time=2020-09-02, status=1, ipAttribution=)]
    2020-09-02 内科新手

    谢谢梅斯提供这么好的信息,学到很多

    0